Use of transdermal alcohol sensors with or without contingency management

Use of transdermal alcohol sensors in conjunction with contingency management to reduce alcohol consumption in people with alcohol dependence attending alcohol treatment services: Feasibility RCT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN46845361

Enrollment

Registered

2023-10-09

Start date

2023-07-05

Completion date

Unknown

Last updated

2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Use of transdermal alcohol sensors with or without CM with AUD individuals. Mental and Behavioural Disorders

Interventions

South London and Maudsley NHS Foundation Trust will aid recruitment, the study will be advertised in these services, and key workers will be informed and can pass on this information via a Participant

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Receiving alcohol treatment for an alcohol use disorder in one of the participating South London alcohol services 2. Over 18 years old and over 3. Speak English competently 4. Able to meet throughout the study period 5. Not currently participating in any other research trials 6. Willing to provide informed consent to participate

Exclusion criteria

Exclusion criteria: 1. Current use of any illegal/addictive substances (excluding cannabis and smoking) 2. Under 18 years old 3. Cannot speak English

Design outcomes

Primary

Measure	Time frame
Feasibility will be measured and defined by: 1. Enrolment measured using recruitment rate, the number of participants who are approached and who enrol, number of staff approached and refer participants at the recruitment stage 2. Participation measured using the number who complete the intervention, attendance rate, and compliance measured at each research visit (days 2, 4, 6, 8, 10, and 12) during the two-week study participation period 3. Device tampering/malfunction measured using the % of removed minutes, % of minutes of tampered data, % of minutes with missing data, reported battery issues, the number of meetings not attended and the number of additional meetings booked, and the number of devices returned measured at each research visit (days 2, 4, 6, 8, 10, and 12) during the two-week study participation period 4. TAS for CM implementation measured using CM vouchers provided at research visits in line with TAC device recorded data (days 2, 4, 6, 8, 10, and 12) during the two-week participation period	—

Measure

Time frame

Feasibility will be measured and defined by: 1. Enrolment measured using recruitment rate, the number of participants who are approached and who enrol, number of staff approached and refer participants at the recruitment stage 2. Participation measured using the number who complete the intervention, attendance rate, and compliance measured at each research visit (days 2, 4, 6, 8, 10, and 12) during the two-week study participation period 3. Device tampering/malfunction measured using the % of removed minutes, % of minutes of tampered data, % of minutes with missing data, reported battery issues, the number of meetings not attended and the number of additional meetings booked, and the number of devices returned measured at each research visit (days 2, 4, 6, 8, 10, and 12) during the two-week study participation period 4. TAS for CM implementation measured using CM vouchers provided at research visits in line with TAC device recorded data (days 2, 4, 6, 8, 10, and 12) during the two-week participation period

—

Secondary

Measure	Time frame
1. TAS acceptability measured using the post-wear survey at the final research visit (day 15) 2. TAS accuracy measured using TAC device recorded data and self-report data collected at each research visit (days 2, 4, 6, 8, 10, and 12) during the two-week study period	—

Countries

England, United Kingdom

Contacts

Public ContactEileen Brobbin

eileen.brobbin@kcl.ac.uk+44 (0)7758287265

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 6, 2026